News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Seven biotech giants spent $15B+ in May on rare disease, vaccines, and ADCs
Angelini paid $4.1B for Catalyst, Lilly bought three vaccine makers, and BMS licensed 13 oncology programs from Hengrui for $15.2B. Here's what each deal targets.
Abivax UC Drug Rebounds After Cancer Scare, Analyst Splits on Label Risk
Abivax shares plunged 44% then recovered 40% as four Wall Street firms weighed nine malignancy cases against strong efficacy data. The real question: how many analysts will stick around if a black box warning lands?
Three biotech obesity plays face acquisition pressure as weight loss drugs race heats up
Lilly, Viking, and Kailera are emerging takeover targets as larger pharma companies move to consolidate obesity treatment pipelines. Here's what to watch in the consolidation wave.
India's Hospitals Grow Revenue 18% as Bed Expansions Squeeze Margins
Listed Indian hospitals posted 18% YoY sales growth in Q4 FY26, but new bed additions kept EBITDA margins flat. Mature units still earned 25.5% margins — here's who won and who stumbled.
NTA denies NEET exam paper leak, warns of fraud charges
India's National Testing Agency dismissed social media claims of a leaked or sold NEET-UG 2026 re-exam paper, calling them false and aimed at exploiting student anxiety. The retest is scheduled for June 21.
India delays anaemia data from health survey, swaps blood test method
NFHS-6 excluded haemoglobin testing due to concerns over capillary sampling. New venous-blood survey from ICMR expected to fill gap with more accurate results.
Two Ebola suspects in Hyderabad test negative; thermal screening catches fever cases
Telangana set up a 10-bed isolation ward at Gandhi Hospital after two Sudanese nationals tested negative for Ebola. Airport thermal screening and intake protocols caught both cases before spread.
India's monsoon heat will extend summer stress to 1.2B people by 2050
New research from IIT Gandhinagar and US universities shows uncompensable heat stress will surge during monsoon months (July-October) as warming intensifies, affecting nearly equivalent populations as summer peaks.
Payers Use AI to Deny Claims Providers Won't Fight—Hospitals Must Adapt
Insurance companies are using AI to strategically target low-appeal denials, costing hospitals billions. Revenue cycle leaders now need analytics to spot patterns payers exploit.
Maternal Care Needs AI to Spot Slow-Building Risk, Not More Data
Labor and delivery units face staff shortages and closures while subtle warning signs compound unnoticed. One health tech CEO argues AI pattern-recognition tools, not additional devices, can help clinicians act earlier and more consistently.
Biopharma's real edge isn't discovery—it's scaling what you've found
BioPharma Dive argues that drug innovation alone no longer wins in biopharma. The competitive advantage now sits in the systems that turn laboratory breakthroughs into manufacturable, deployable products at speed.
Nuclear medicine supply chains need precision logistics to scale production
Nuclear medicine doses require hour-tight delivery windows and specialized handling. A new focus on logistics optimization is reshaping how radiopharmaceuticals reach patients faster.